Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ELI LILLY & Co Director's Dealing 2017

Dec 5, 2017

29745_dirs_2017-12-05_2714deec-b596-48aa-8357-d4a488eb0ce5.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LILLY ELI & CO (LLY)
CIK: 0000059478
Period of Report: 2017-12-03

Reporting Person: Zakrowski Donald A (Chief Accounting Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2017-12-03 Common Stock M 3281 Acquired 4167 Direct
2017-12-03 Common Stock F 1070 $85.32 Disposed 3097 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2017-12-03 Restricted Stock Unit $ M 3281 Disposed 2017-12-03 Common Stock (3281.0) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 3348 Indirect

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.